Expression of c-kit proto-oncogene in canine mastocytoma: A kinetic study using real-time polymerase chain reaction

Lauretta Turin, Fabio Acocella, Damiano Stefanello, Angelo Oseliero, Danilo Fondrini, Stefano Brizzola, Federica Riva

Research output: Contribution to journalArticle

Abstract

KIT receptor, the c-kit gene product, is thought to play a major role in canine mastocytoma, one of the most common neoplastic diseases in dogs. In the present study, the expression of c-kit proto-oncogene in blood and in tumor biopsies from 41 dogs with histologically confirmed mastocytoma at different grades of cellular differentiation and 5 negative control dogs was investigated using real-time (quantitative) reverse transcription-polymerase chain reaction (RRT-PCR). The animals were followed up for over 1 year after surgery in order to characterize the kinetics of c-kit expression in blood. Transcript mRNAs extracted from blood at different time points after surgery and from tumor tissue surgically removed from each dog were used in a quantitative RRT-PCR assay targeting the extracellular coding region of the c-kit gene. Tissues constitutively expressing c-kit (brain and spleen) were used as positive controls. Levels of expression of c-kit were higher in tumor biopsies than in blood; the blood level decreased in the patients between 1 and 3 months after surgery. No KIT expression was detected in blood from the 5 dogs not affected by mastocytoma (negative controls). The RRT-PCR appears to be a suitable method for sensitive and quantitative detection of c-kit gene expression in canine blood and neoplastic tissues. Although c-kit expression levels measured by RRT-PCR do not correlate with prognosis, they confirm that surgery remains the main treatment to reduce circulating mastocytes and that circulating mast cells can be detected even in benign highly differentiated forms of mastocytoma such as grade I.

Original languageEnglish
Pages (from-to)343-349
Number of pages7
JournalJournal of Veterinary Diagnostic Investigation
Volume18
Issue number4
Publication statusPublished - Jul 2006

Fingerprint

Mastocytoma
proto-oncogenes
Proto-Oncogenes
Canidae
Real-Time Polymerase Chain Reaction
quantitative polymerase chain reaction
kinetics
dogs
blood
Reverse Transcription
surgery
reverse transcriptase polymerase chain reaction
Dogs
Polymerase Chain Reaction
neoplasms
biopsy
Proto-Oncogene Proteins c-kit
Dog Diseases
Biopsy
Neoplasms

Keywords

  • C-kit
  • Canine
  • Mastocytoma
  • Oncogene
  • Real-time reverse transcription-PCR

ASJC Scopus subject areas

  • Microbiology
  • veterinary(all)

Cite this

Expression of c-kit proto-oncogene in canine mastocytoma : A kinetic study using real-time polymerase chain reaction. / Turin, Lauretta; Acocella, Fabio; Stefanello, Damiano; Oseliero, Angelo; Fondrini, Danilo; Brizzola, Stefano; Riva, Federica.

In: Journal of Veterinary Diagnostic Investigation, Vol. 18, No. 4, 07.2006, p. 343-349.

Research output: Contribution to journalArticle

Turin, L, Acocella, F, Stefanello, D, Oseliero, A, Fondrini, D, Brizzola, S & Riva, F 2006, 'Expression of c-kit proto-oncogene in canine mastocytoma: A kinetic study using real-time polymerase chain reaction', Journal of Veterinary Diagnostic Investigation, vol. 18, no. 4, pp. 343-349.
Turin, Lauretta ; Acocella, Fabio ; Stefanello, Damiano ; Oseliero, Angelo ; Fondrini, Danilo ; Brizzola, Stefano ; Riva, Federica. / Expression of c-kit proto-oncogene in canine mastocytoma : A kinetic study using real-time polymerase chain reaction. In: Journal of Veterinary Diagnostic Investigation. 2006 ; Vol. 18, No. 4. pp. 343-349.
@article{ae856a96c2914323ad584bc77898a8a4,
title = "Expression of c-kit proto-oncogene in canine mastocytoma: A kinetic study using real-time polymerase chain reaction",
abstract = "KIT receptor, the c-kit gene product, is thought to play a major role in canine mastocytoma, one of the most common neoplastic diseases in dogs. In the present study, the expression of c-kit proto-oncogene in blood and in tumor biopsies from 41 dogs with histologically confirmed mastocytoma at different grades of cellular differentiation and 5 negative control dogs was investigated using real-time (quantitative) reverse transcription-polymerase chain reaction (RRT-PCR). The animals were followed up for over 1 year after surgery in order to characterize the kinetics of c-kit expression in blood. Transcript mRNAs extracted from blood at different time points after surgery and from tumor tissue surgically removed from each dog were used in a quantitative RRT-PCR assay targeting the extracellular coding region of the c-kit gene. Tissues constitutively expressing c-kit (brain and spleen) were used as positive controls. Levels of expression of c-kit were higher in tumor biopsies than in blood; the blood level decreased in the patients between 1 and 3 months after surgery. No KIT expression was detected in blood from the 5 dogs not affected by mastocytoma (negative controls). The RRT-PCR appears to be a suitable method for sensitive and quantitative detection of c-kit gene expression in canine blood and neoplastic tissues. Although c-kit expression levels measured by RRT-PCR do not correlate with prognosis, they confirm that surgery remains the main treatment to reduce circulating mastocytes and that circulating mast cells can be detected even in benign highly differentiated forms of mastocytoma such as grade I.",
keywords = "C-kit, Canine, Mastocytoma, Oncogene, Real-time reverse transcription-PCR",
author = "Lauretta Turin and Fabio Acocella and Damiano Stefanello and Angelo Oseliero and Danilo Fondrini and Stefano Brizzola and Federica Riva",
year = "2006",
month = "7",
language = "English",
volume = "18",
pages = "343--349",
journal = "Journal of Veterinary Diagnostic Investigation",
issn = "1040-6387",
publisher = "American Association of Veterinary Laboratory Diagnosticians",
number = "4",

}

TY - JOUR

T1 - Expression of c-kit proto-oncogene in canine mastocytoma

T2 - A kinetic study using real-time polymerase chain reaction

AU - Turin, Lauretta

AU - Acocella, Fabio

AU - Stefanello, Damiano

AU - Oseliero, Angelo

AU - Fondrini, Danilo

AU - Brizzola, Stefano

AU - Riva, Federica

PY - 2006/7

Y1 - 2006/7

N2 - KIT receptor, the c-kit gene product, is thought to play a major role in canine mastocytoma, one of the most common neoplastic diseases in dogs. In the present study, the expression of c-kit proto-oncogene in blood and in tumor biopsies from 41 dogs with histologically confirmed mastocytoma at different grades of cellular differentiation and 5 negative control dogs was investigated using real-time (quantitative) reverse transcription-polymerase chain reaction (RRT-PCR). The animals were followed up for over 1 year after surgery in order to characterize the kinetics of c-kit expression in blood. Transcript mRNAs extracted from blood at different time points after surgery and from tumor tissue surgically removed from each dog were used in a quantitative RRT-PCR assay targeting the extracellular coding region of the c-kit gene. Tissues constitutively expressing c-kit (brain and spleen) were used as positive controls. Levels of expression of c-kit were higher in tumor biopsies than in blood; the blood level decreased in the patients between 1 and 3 months after surgery. No KIT expression was detected in blood from the 5 dogs not affected by mastocytoma (negative controls). The RRT-PCR appears to be a suitable method for sensitive and quantitative detection of c-kit gene expression in canine blood and neoplastic tissues. Although c-kit expression levels measured by RRT-PCR do not correlate with prognosis, they confirm that surgery remains the main treatment to reduce circulating mastocytes and that circulating mast cells can be detected even in benign highly differentiated forms of mastocytoma such as grade I.

AB - KIT receptor, the c-kit gene product, is thought to play a major role in canine mastocytoma, one of the most common neoplastic diseases in dogs. In the present study, the expression of c-kit proto-oncogene in blood and in tumor biopsies from 41 dogs with histologically confirmed mastocytoma at different grades of cellular differentiation and 5 negative control dogs was investigated using real-time (quantitative) reverse transcription-polymerase chain reaction (RRT-PCR). The animals were followed up for over 1 year after surgery in order to characterize the kinetics of c-kit expression in blood. Transcript mRNAs extracted from blood at different time points after surgery and from tumor tissue surgically removed from each dog were used in a quantitative RRT-PCR assay targeting the extracellular coding region of the c-kit gene. Tissues constitutively expressing c-kit (brain and spleen) were used as positive controls. Levels of expression of c-kit were higher in tumor biopsies than in blood; the blood level decreased in the patients between 1 and 3 months after surgery. No KIT expression was detected in blood from the 5 dogs not affected by mastocytoma (negative controls). The RRT-PCR appears to be a suitable method for sensitive and quantitative detection of c-kit gene expression in canine blood and neoplastic tissues. Although c-kit expression levels measured by RRT-PCR do not correlate with prognosis, they confirm that surgery remains the main treatment to reduce circulating mastocytes and that circulating mast cells can be detected even in benign highly differentiated forms of mastocytoma such as grade I.

KW - C-kit

KW - Canine

KW - Mastocytoma

KW - Oncogene

KW - Real-time reverse transcription-PCR

UR - http://www.scopus.com/inward/record.url?scp=33746835305&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33746835305&partnerID=8YFLogxK

M3 - Article

C2 - 16921872

AN - SCOPUS:33746835305

VL - 18

SP - 343

EP - 349

JO - Journal of Veterinary Diagnostic Investigation

JF - Journal of Veterinary Diagnostic Investigation

SN - 1040-6387

IS - 4

ER -